Enlivex Therapeutics (Enlivex Therapeutics) Accumulated Depreciation : $-2.74 Mil (As of Sep. 2023)

View and export this data going back to 2014. Start your Free Trial

What is Enlivex Therapeutics Accumulated Depreciation?

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

Enlivex Therapeutics's quarterly accumulated depreciation declined from Mar. 2023 ($-3.94 Mil) to Jun. 2023 ($-2.53 Mil) but then increased from Jun. 2023 ($-2.53 Mil) to Sep. 2023 ($-2.74 Mil).

Enlivex Therapeutics's annual accumulated depreciation increased from Dec. 2020 ($-1.02 Mil) to Dec. 2021 ($-1.97 Mil) and increased from Dec. 2021 ($-1.97 Mil) to Dec. 2022 ($-3.53 Mil).

Enlivex Therapeutics Accumulated Depreciation Historical Data

The historical data trend for Enlivex Therapeutics's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Enlivex Therapeutics Accumulated Depreciation Chart

Enlivex Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accumulated Depreciation

Get a 7-Day Free Trial

-0.51

-1.02

-1.97

-3.53

-2.87

Enlivex Therapeutics Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Accumulated Depreciation	Get a 7-Day Free Trial															-3.53	-3.94	-2.53	-2.74	-2.87

Enlivex Therapeutics Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

Enlivex Therapeutics Accumulated Depreciation Related Terms

Thank you for viewing the detailed overview of Enlivex Therapeutics's Accumulated Depreciation provided by GuruFocus.com. Please click on the following links to see related term pages.

Enlivex Therapeutics (Enlivex Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Enlivex Therapeutics Ltd (NAS:ENLV) » Definitions » Accumulated Depreciation

Comparable Companies

Traded in Other Exchanges

ENLV:Israel 1BT:Germany

Address

14 Einstein Street, Nes Ziona, ISR, 7403618

Website

https://www.enlivex.com

Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.